This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Baker Heart and Diabetes Institute, Zora Biosciences Oy. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Dianna Magliano: Innovator in Diabetes Detection
Introduction
Dianna Magliano is a prominent inventor based in St Kilda West, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the early detection of diabetes and related conditions. Her innovative work has the potential to improve health outcomes for many individuals at risk of developing serious diseases.
Latest Patents
Dianna holds a patent for her invention titled "Methods for prediction and early detection of diabetes." This patent describes an in vitro method for assessing whether a subject is at risk of developing or is suffering from fatty liver disease. The method involves assaying a sample from the subject to determine the concentration of specific fatty liver biomarkers. By comparing these biomarker values to a control, the method can effectively identify individuals at increased risk of fatty liver disease.
Career Highlights
Throughout her career, Dianna has worked with notable organizations, including Zora Biosciences Oy and the Baker Heart and Diabetes Institute. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in diabetes and metabolic health.
Collaborations
Dianna has collaborated with talented individuals such as Kevin Huynh and Jonathan Shaw. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in advancing her research and innovations.
Conclusion
Dianna Magliano's work in the field of diabetes detection exemplifies the impact of innovative thinking in healthcare. Her patented methods offer promising solutions for early diagnosis and intervention, ultimately benefiting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile